BioIntelliSense_Sticker Clinicians_view_patient_data_on_tablet-ALI-global December 22, 2020 In 2,500-person trial, partners to validate FDA-cleared BioSticker for clinical confidence in detecting infection Cambridge,...
SAN DIEGO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
BANNOCKBURN, Ill., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest...
MINNEAPOLIS, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
- Early signal of efficacy with trends toward lower mortality and shorter duration of mechanical ventilation in patients treated with...
FOSTER CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking...
JERSEY CITY, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously...
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused...
Clinically Proven to Increase the Motivation to Quit, the Company’s Device is the First Ever FDA-Cleared Breath Sensor for Consumer...
RenovaCare 2021 Outlook RenovaCare Discusses 2020 Highlights and Provides 2021 Outlook RenovaCare Chairman & CEO, Alan L. Rubino Alan L....
- Strategic investment from single biotech-focused institutional investor - - Enables clinical development of both fadraciclib and CYC140 in hematological...
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 22, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO...
HOUSTON, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company developing potential new medicines for patients...
Companies will co-develop inactivated vaccine candidate, COVAXIN™, to prevent COVID-19 infection in the US Builds upon the promising safety and...
Latest publication confirms BET inhibitors reduce the levels of critical receptors used by SARS-CoV-2 (COVID-19) to gain entry into cells,...
CELEBRATION, Fla., Dec. 22, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery...
The dHydronator’s SanitiZen® technology has been proven to reduce the microbial load level of cannabis from failing laboratory testing and...
Beyond retinal detachment, lead candidate ONL1204 will also advance into the chronic conditions of glaucoma and dry age-related macular degeneration...
SAN FRANCISCO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced dosing of the first patient in the...
-- Study met primary endpoint and all key secondary endpoints with statistically significant and clinically meaningful reductions in weight and...